Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biological_pathway
|
| gptkbp:activatedBy |
gptkb:tissue_plasminogen_activator
gptkb:urokinase |
| gptkbp:associatedWith |
pulmonary embolism
deep vein thrombosis |
| gptkbp:component |
gptkb:tissue_plasminogen_activator
gptkb:plasminogen_activator_inhibitor-1 gptkb:urokinase gptkb:plasminogen plasmin alpha-2-antiplasmin |
| gptkbp:countermeasures |
gptkb:coagulation_system
|
| gptkbp:function |
dissolution of blood clots
|
| gptkbp:inhibitedBy |
gptkb:plasminogen_activator_inhibitor-1
alpha-2-antiplasmin |
| gptkbp:location |
blood plasma
|
| gptkbp:regulates |
hemostasis
|
| gptkbp:relatedTo |
fibrinolysis
|
| gptkbp:significance |
thrombolytic therapy
|
| gptkbp:suffersFrom |
fibrinolysis disorder
|
| gptkbp:bfsParent |
gptkb:C1_esterase_inhibitor
gptkb:C1-inhibitor gptkb:tPA |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
fibrinolytic system
|